Knowledge of Drug–Food Interactions Among Healthcare Professionals Working in Public Hospitals in Ethiopia
Natanim Degefu,Melaku Getachew,Firehiwot Amare
DOI: https://doi.org/10.2147/JMDH.S389068
2022-11-15
Journal of Multidisciplinary Healthcare
Abstract:Natanim Degefu, 1 Melaku Getachew, 2 Firehiwot Amare 3 1 Department of Pharmaceutics, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; 2 Department of Emergency Medicine and Critical Care, School of Medicine, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; 3 Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia Correspondence: Firehiwot Amare, Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia, Tel +251 913183027, Email Background: Drug–food interactions can result in unfavorable outcomes during the treatment of patients. Healthcare professionals (HCPs) should advise patients on drug–food interactions. Knowledge of such interactions is crucial to avoid their occurrence. However, there is no information regarding the knowledge of HCPs about drug–food interactions in Harari Regional State. Objective: To assess knowledge of drug–food interactions and associated factors among HCPs working in public hospitals in Harari Regional State, Eastern Ethiopia from April 15 to May 15, 2022. Methods: A cross-sectional study was conducted in public hospitals in Harari Regional State, Eastern Ethiopia, among 251 HCPs. After stratification was done based on profession (pharmacists, nurses, and doctors), the sample size was proportionally allocated for the respective groups. Data were collected using a standardized self-administered questionnaire, entered into Epi-Data 3.1 and analyzed using Statistical Package for Social Sciences 26.0. Descriptive statistics were used to summarize variables. Multivariable logistic regression was done to determine factors associated with knowledge of drug–food interactions. P < 0.05 was used to declare significant association. Results: Among the HCPs who completed the questionnaire, 56 (22.3%), 36 (14.3%), and 159 (63.3%) were doctors, pharmacists, and nurses, respectively. The majority of the HCPs were males (174 (69.3%)). The mean age of the HCPs was 27.6± 3.8. The mean knowledge score±SD of the HCPs was 28.6± 6.6 out of an overall score of 59. The HCPs poorly identified drug–food interactions and the correct administration time of drugs relative to meals. Being a pharmacist (AOR: 2.8, CI: 1.3– 6.4, p-value=0.012), and working at a tertiary hospital (AOR: 3.9, CI: 2.1– 7.3, p-value < 0.001), were associated with higher knowledge of drug-food interactions. Conclusion: The HCPs in this study had inadequate knowledge of drug–food interactions. Thus, additional educational courses and training should be provided in order to improve knowledge regarding drug-food interaction. Keywords: drug–food interaction, knowledge, healthcare professionals, public hospitals Food is one of the core components of patients' therapeutic plans and healthy lifestyles. Many food can be used in the prevention and treatment of diseases. 1–3 As a result, the use of healthy food is now increasing among patients. 4 The concomitant use of food and drugs should be of great concern due to potential interactions between food products and drugs. 1–3 Drug–food interaction is one of the constraints for the safe and effective delivery of pharmacotherapy. It can occur with prescription and non-prescription products. Drug–food interactions can result in a decrease in drug efficacy or an increase in drug toxicity. 5–7 Clinically significant drug–food interactions can be classified into pharmaceutical, pharmacokinetic, and pharmacodynamics based on the mechanisms involved. 8,9 Pharmaceutical interaction involves physicochemical reactions that occur within delivery devices, such as enteral feeding tubes. Pharmacokinetic interaction occurs when the processes related to absorption, distribution, metabolism, and excretion of drugs varied because of food presence. Divalent cations found in dairy products forming a chelate with ciprofloxacin, CYP3A4 metabolism of simvastatin inhibited by grapefruit juice, and lithium and sodium competing for tubular reabsorption in the kidney are examples of pharmacokinetic interactions. On the other hand, pharmacodynamic interaction happens when foods alter the clinical effect of a drug on the body. The result of the interaction can be additive, synergistic, or antagonistic. A diet containing high vitamin K antagonizing the therapeutic effects of warfarin is an example of pharmacodynamic interactions. 8–13 The degree of interaction depends on the physical and chemical nature of the drug, the formulation, the type of -Abstract Truncated-
health care sciences & services